Non-invasive heart monitor tested against standard method in shock patients
NCT ID NCT02728791
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compared a non-invasive device (ClearSight) with a standard invasive method (transpulmonary thermodilution) for measuring heart function in 42 ICU patients with shock or low cardiac output. The goal was to see if the non-invasive device could be used routinely. Researchers looked at how well the two methods agreed on cardiac index, blood pressure, and stroke volume.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If the non-invasive device proves accurate enough, it could replace invasive monitoring in some ICU patients, reducing complications.
What could go wrong
This is a small, completed correlation study (42 patients) that only compares measurements; it does not test whether using the device improves patient outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHOCK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU BREST, Hôpital de la Cavale Blanche
Brest, 29200, France